Chemours releases third quarter 2026 earnings
The chemical manufacturer reports its financial results for the three-month period.
See the latest news and media coverage for Chemours. We track all announcements, press releases, and industry mentions in real time, all in one place.
Global chemistry company providing industrial and specialty chemicals
chemours.comLast updated
In short: Chemours reported third-quarter results, set 2026 adjusted EBITDA guidance of $775M-$800M and forecast lower Q4 sales.
The chemical manufacturer reports its financial results for the three-month period.
Net income attributable to Chemours was $196 million, or $1.29 per diluted share, while Adjusted EBITDA reached $200 million.
FY2025 revenue reached $5.8B with $742M Adjusted EBITDA, while the company outlines a pathway to thrive through operational excellence and portfolio management.
The company pays its 50% share of approximately $180 million to resolve litigation with North Carolina and local entities regarding historical PFAS discharges.
The company expects net sales growth of around 2% and free cash flow conversion of 15%-20%, with capital expenditures of $220M-$230M.
Chemours (NYSE:CC) reported quarterly earnings of $0.21 per share which missed the analyst consensus...
Leverage remains the central counterweight to the cash flow improvement. Chemours reported Q2 net leverage of 4.4 times adjusted EBITDA, while its long-term objective is...
On September 10, DuPont, together with Chemours, Corteva and its subsidiary EIDP (the former DuPont entity, collectively referred to as Corteva with its parent company),reached...
Track Chemours and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to Chemours and other trending companies.